GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly.
Pierri I, Clavio M, Beltrami G, Cavaliere M, Lanza L, Miglino M, Canepa L, Pietrasanta D, Ballerini F, Quintino S, Gatto S, Celesti L, Carrara P, Varese P, Gobbi M.
Pierri I, et al. Among authors: varese p.
J Exp Clin Cancer Res. 1999 Mar;18(1):55-60.
J Exp Clin Cancer Res. 1999.
PMID: 10374678
Clinical Trial.